Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis: Peer Mentoring Program
1 other identifier
interventional
10
1 country
1
Brief Summary
Inflammatory arthritis (IA) is a major cause of long-term disability. Peer support may be a solution to the common problem of delayed treatment. Early peer support may result in improved use of therapy, higher self-efficacy, reduced anxiety, and improved coping in the first two years post-diagnosis. The whole intervention study comprises of two parts: The first part involves the development and testing of a peer mentor training initiative, which is called "Peer to Peer Mentoring: Facilitating Individuals with Early Inflammatory Arthritis to Manage their Arthritis - Peer Mentor Training". The second part, which is the focus of this study, involves the delivery of a one-on-one peer support intervention from a trained peer mentor to an individual newly diagnosed with EIA. The feasibility and acceptability of the program will be determined, as well as the health outcomes following the participation of the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 21, 2010
CompletedFirst Posted
Study publicly available on registry
January 22, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedDecember 29, 2011
December 1, 2011
1.7 years
January 21, 2010
December 23, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
DMARD adherence
0, 3, 6 months
Secondary Outcomes (5)
coping efficacy
0, 3 6 months
self-management
0, 3, 6 months
anxiety
0, 3, 6 months
self efficacy
0, 3, 6 months
social support
0, 3, 6 months
Interventions
A quasi-experimental, before and after study design will obtain data for planning and implementing a larger-scale study. Exposures and outcomes will be measured at baseline, 3 months (immediate post 12-week program) and 6 months (3 months post-program). Ten individuals with EIA will be recruited by brief screening interviews to ensure they meet inclusion criteria. Each pair of peer mentor and EIA participant will meet at SHSC for an initial contact. EIA participants will receive informational, emotional and appraisal support from trained peer mentors by telephone or neutral private location at a time convenient for both parties, at least once a week for 12 weeks.
Eligibility Criteria
You may qualify if:
- Have EIA disease duration within 6-52 weeks
- At least 3 swollen joints, assessed by the treating rheumatologist, OR positive compression test for the metacarpophalangeal joints OR positive compression test for the metatarsophalangeal joints OR at least 30 minutes of morning stiffness
- Prescription of a DMARD/biologic by the treating rheumatologist
- Ability to speak and understand English without the aid of a secondary support person; AND
- Capability to provide informed consent.
You may not qualify if:
- IA disease duration less than 6 weeks or greater than 1 year
- Previous or ongoing DMARD or biologic treatment
- Inability to speak or read grade 6 English; AND
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sunnybrook Health Sciences Centrelead
- Canadian Arthritis Networkcollaborator
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Related Publications (1)
Sandhu S, Veinot P, Embuldeniya G, Brooks S, Sale J, Huang S, Zhao A, Richards D, Bell MJ. Peer-to-peer mentoring for individuals with early inflammatory arthritis: feasibility pilot. BMJ Open. 2013 Mar 1;3(3):e002267. doi: 10.1136/bmjopen-2012-002267.
PMID: 23457326DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary J Bell, MD, FRCPC
Rheumatologist, Sunnybrook Health Sciences Centre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Rheumatologist
Study Record Dates
First Submitted
January 21, 2010
First Posted
January 22, 2010
Study Start
January 1, 2010
Primary Completion
September 1, 2011
Study Completion
December 1, 2011
Last Updated
December 29, 2011
Record last verified: 2011-12